Latest Smith, Kline & French Stories
GlaxoSmithKline Continues to Blame Patients Crippled by Poligrip HOUSTON, March 3 /PRNewswire-USNewswire/ -- Pharmaceutical giant, GlaxoSmithKline (GSK), has taken the extraordinary step of warning doctors about the dangers posed by its denture cream, while continuing to blame and mislead patients crippled by its products. On February 18, the company announced that it would remove zinc from all of its denture adhesive products, citing concerns about the "safety and health" of its...
Because the safety and health of our consumers is our primary concern, GlaxoSmithKline (GSK) Consumer Healthcare is issuing a Consumer Advisory warning consumers about the potential health risks associated with long-term excessive use of zinc-containing denture adhesives.GSK has taken voluntary, precautionary action to end the manufacture and supply of its zinc-containing denture adhesives marketed across many countries.We are taking these actions because we have become aware of potential...
Untold Numbers of Consumers Still Left Disabled By Its Products WASHINGTON, Feb. 18 /PRNewswire-USNewswire/ -- GlaxoSmithKline, the maker of popular denture adhesives Poligrip and Super Poligrip, announced today that it will remove zinc from all of its denture adhesive products. The pharmaceutical giant has added the potentially hazardous mineral to its adhesives for decades, despite overwhelming evidence that consuming large quantities of zinc over an extended period of time can cause...
PHILADELPHIA, Feb. 1 /PRNewswire-FirstCall/ -- On Thursday, February 4, 2010, GlaxoSmithKline plc will announce its full year financial results for the year ended December 31, 2009. It is anticipated that the announcement will be released to the London Stock Exchange at approximately 7:00am Eastern Standard Time (EST) and available at www.gsk.com. Following the announcement, Andrew Witty, Chief Executive Officer, and Julian Heslop, Chief Financial Officer, will hold a briefing meeting for...
CINCINNATI, Dec. 22 /PRNewswire/ -- Prasco Laboratories announced today that they have signed a distribution and supply agreement with Stiefel Laboratories, Inc., a GlaxoSmithKline company, for Clobetasol Propionate Foam 0.05%, the latest product in Prasco's line of authorized generics. Under the terms of the agreement, Prasco will market and distribute Clobetasol Propionate Foam 0.05% in 50g and 100g canisters in the U.S. under the Prasco label. "We are pleased to provide pharmacists and...
PARSIPPANY, N.J. and ANN ARBOR, Mich., Dec. 16 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc [GSK] (NYSE: GSK) and NanoBio Corporation today announced an exclusive licensing agreement in the United States and Canada for the over-the-counter (OTC) use of NB-001, a novel, patented compound representing the next advance in the treatment of cold sores. Developed by NanoBio, NB-001 provides significant antimicrobial activity against the virus that causes cold sores, herpes labialis. Cold sores...
DUBLIN, Ireland, November 2 /PRNewswire-FirstCall/ -- The Board of Directors of Shire plc (LSE: SHP, NASDAQ: SHPGY) announces that Mr David Stout joined the Board as a Non Executive Director with effect from 31 October 2009. Mr Stout has extensive pharmaceutical experience. Most recently he was President, Pharmaceutical Operations at GSK. In this position he had responsibility for pharmaceutical operations in the United States, Europe, Japan and all other International Markets. Mr...
NEW YORK, Oct. 16 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Allergan Inc.: PharmaVitae Profile http://www.reportlinker.com/p0155102/Reportlinker-Adds-Allergan-Inc-PharmaVitae-Profile.html Introduction This analysis examines the historical and forecast performance for Allergan in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of...
PHILADELPHIA, Oct. 8 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO's motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. David J. Kappos and the United States Patent and Trademark Office). GSK and the USPTO will file a joint...
PITTSBURGH, Oct. 1 /PRNewswire/ -- In celebration of mothers and the special role they play in their families' lives, the makers of Aquafresh® announced the "Amazing Mom" Celebration contest for moms in the Phoenix area. The Aquafresh "Amazing Mom" Celebration invites children 6 years of age and older to write in and tell Aquafresh what makes their mom special. If selected, Aquafresh will treat her and forty-nine other moms to a day of relaxation and pampering at Spa Avania at Hyatt...
